- Joined
- Apr 10, 2001
- Posts
- 66,708
Amid broad mistrust of FDA and Trump administration, drug companies seek to reassure public about Covid-19 vaccine safety
SEPTEMBER 8, 2020
WASHINGTON — A group of nine leading pharmaceutical and biotechnology companies pledged on Tuesday to only seek approval for Covid-19 vaccines demonstrated to be safe and effective, an apparent attempt to provide public reassurance despite the widely held view that the Covid-19 vaccine development process is politically tainted.
In a statement, the companies pledged to “make the safety and well-being of vaccinated individuals our top priority.” The vaccine developers said they would continue to impose high ethical and scientific standards on the vaccine-testing process, and apply for government authorizations only “after demonstrating safety and efficacy through a Phase 3 clinical study.”
The group of nine companies includes Moderna, AstraZeneca, and the ongoing collaboration between Pfizer and BioNTech — three of the Covid-19 vaccine efforts that have advanced into late-stage clinical trials, and whose vaccine candidates are likely to be considered for emergency approvals in the coming months. Top executives at Merck, GlaxoSmithKline, Johnson & Johnson, Sanofi, and Novavax also signed the pledge.
SEPTEMBER 8, 2020
WASHINGTON — A group of nine leading pharmaceutical and biotechnology companies pledged on Tuesday to only seek approval for Covid-19 vaccines demonstrated to be safe and effective, an apparent attempt to provide public reassurance despite the widely held view that the Covid-19 vaccine development process is politically tainted.
In a statement, the companies pledged to “make the safety and well-being of vaccinated individuals our top priority.” The vaccine developers said they would continue to impose high ethical and scientific standards on the vaccine-testing process, and apply for government authorizations only “after demonstrating safety and efficacy through a Phase 3 clinical study.”
The group of nine companies includes Moderna, AstraZeneca, and the ongoing collaboration between Pfizer and BioNTech — three of the Covid-19 vaccine efforts that have advanced into late-stage clinical trials, and whose vaccine candidates are likely to be considered for emergency approvals in the coming months. Top executives at Merck, GlaxoSmithKline, Johnson & Johnson, Sanofi, and Novavax also signed the pledge.
